sales@businessmarketinsights.com     UK: +442081254005
   

Middle East and Africa Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare) and Geography

Code: TIPRE00016325 | Pages: 113 | Industry: Medical Device | Date: Nov 2020
Covid

Market Introduction

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

Market Overview and Dynamics

The Middle East & Africa Neuromodulation market is projected to reach US$  834.67 million by 2027 from US$  410.80 million in 2019; it is estimated to grow with a CAGR of 9.6% from 2020 to 2027. The growth of the Middle East & Africa neuromodulation market is attributed to the increasing incidence of neurological disorders, growing developments in neuromodulation technology. However, high cost of neuromodulation devices the growth of market in this region. leading to restraining the growth of the market.

Key Market Segments

Based on technology, the Middle East & Africa neuromodulation market is segmented into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment held a larger share of the market. External (non-invasive) neuromodulation is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the Middle East & Africa neuromodulation market report are World Health Organization, Ministry of Health & Prevention, Parkinson’s Disease & Movement Disorder Society (PDMDS), and Garvan Institute, and Ministry of Health and Family Welfare.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim.

 

Reasons to buy the report

  • To understand the Middle East & Africa neuromodulation market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Middle East & Africa neuromodulation market
  • To efficiently plan M&A and partnership deals in the Middle East & Africa neuromodulation market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Middle East & Africa neuromodulation market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Middle East & Africa neuromodulation market

MIDDLE EAST & AFRICA NEUROMODULATION MARKET SEGMENTATION

By Technology

  • External (Non-Invasive) Neuromodulation
    • Respiratory Electrical Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
    • Deep Brain Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
    • Spinal Cord Stimulation
    • Vagus Nerve Stimulation

By Application

  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine

 

By End User

  • Hospitals
  • Clinics
  • Home Healthcare

 

By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • RoMEA

 

Company Profiles

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Neuromodulation Market – By Technology

1.3.2        Neuromodulation Market – By Application

1.3.3        Neuromodulation Market – By End User

1.3.4        Middle East and Africa Neuromodulation Market – By Country

2.             Neuromodulation Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Middle East and Africa Neuromodulation– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.3       Expert Opinions

5.             Neuromodulation Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Incidence of Neurological Disorders

5.1.2        Growing Developments in Neuromodulation Technology

5.2       Market Restraints

5.2.1        High Cost of Neuromodulation Devices

5.3       Market Opportunities

5.3.1        Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.4       Future Trends

5.4.1        Technological Advancements

5.5       Impact Analysis

6.             Neuromodulation Market Analysis – By Technology

6.1       Overview

6.2       Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

6.3       External Neuromodulation

6.3.1        Overview

6.3.2        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.3        Respiratory Electrical Stimulation (RES)

6.3.3.1      Overview

6.3.3.2      Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.4        Transcutaneous Electrical Nerve Stimulation (TENS)

6.3.4.1      Overview

6.3.4.2      Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.3.5        Transcranial Magnetic Stimulation (TMS)

6.3.5.1      Overview

6.3.5.2      Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4       Internal Neuromodulation

6.4.1        Overview

6.4.2        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.3        Deep Brain Stimulation (DBS)

6.4.3.1      Overview

6.4.3.2      Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.4        Sacral Nerve Stimulation (DBS)

6.4.4.1      Overview

6.4.4.2      Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.5        Gastric Electric Stimulation (GES)

6.4.5.1      Overview

6.4.5.2      Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.6        Spinal Cord Stimulation (SCS)

6.4.6.1      Overview

6.4.6.2      Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

6.4.7        Vagus Nerve Stimulation (VNS)

6.4.7.1      Overview

6.4.7.2      Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.             Neuromodulation Market Analysis – By Application

7.1       Overview

7.2       Neuromodulation Market Share, by Application, 2019 and 2027 (%)

7.3       Chronic Pain Management

7.3.1        Overview

7.3.2        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4       Failed Back Syndrome

7.4.1        Overview

7.4.2        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.5       Epilepsy

7.5.1        Overview

7.5.2        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.6       Tremor

7.6.1        Overview

7.6.2        Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.7       Incontinence

7.7.1        Overview

7.7.2        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.8       Depression

7.8.1        Overview

7.8.2        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.9       Dystonia

7.9.1        Overview

7.9.2        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.10    Gastroparesis

7.10.1     Overview

7.10.2     Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.11    Parkinson’s Disease

7.11.1     Overview

7.11.2     Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.12    Obsessive-Compulsive Disorder (OCD)

7.12.1     Overview

7.12.2     Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

7.13    Migraine

7.13.1     Overview

7.13.2     Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.             Neuromodulation Market Analysis – By End User

8.1       Overview

8.2       Neuromodulation Market Share, by End User, 2019 and 2027, (%)

8.3       Hospitals

8.3.1        Overview

8.3.2        Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Clinics

8.4.1        Overview

8.4.2        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Home Healthcare

8.5.1        Overview

8.5.2        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.             Middle East and Africa Neuromodulation Market Analysis and Forecasts To 2027 – Regional Analysis

9.1.1        Overview

9.1.2        Middle East and Africa: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

9.1.3        Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027  (USD Million)

9.1.3.1      Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.2      Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

9.1.5        Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

9.1.6        Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)

9.1.7        Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1      Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1       Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

9.1.7.2.2       Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3      Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7.4      Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1      UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1       UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2       UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3      UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.8.4      UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.9        South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1      South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2      South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

9.1.9.2.1       South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

9.1.9.2.2       South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.9.3      South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.9.4      South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.          Impact of COVID-19 Pandemic on Middle East and Africa Neuromodulation Market

10.1    Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.          Company Profiles

11.1    Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2    Boston Scientific Corporation

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    Medtronic

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    NeuroPace, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5    NeuroSigma, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    Nevro Corp.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7    Synapse Biomedical Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8    Soterix Medical Inc

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9    Integer Holdings Corporation

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 Magstim

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Products and Services

11.10.4   Financial Overview

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.          Appendix

12.1    Glossary of Terms


LIST OF TABLES

Table 1.             North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 13.          Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 18.          Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Europe: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 22.          Europe: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 23.          Europe: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          Europe: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25.          Europe: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 26.          Germany: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 27.          Germany: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 28.          Germany: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Germany: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 30.          Germany: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          UK: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 32.          UK: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          UK: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 34.          UK: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 35.          UK: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 36.          France: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 37.          France: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 38.          France: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          France: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 40.          France: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 41.          Spain: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 42.          Spain: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          Spain: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          Spain: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 45.          Spain: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 46.          Italy: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 47.          Italy: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 48.          Italy: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 49.          Italy: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 50.          Italy: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 51.          Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 52.          Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 53.          Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 54.          Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 55.          Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 56.          China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 57.          China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 58.          China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 59.          China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 60.          China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 62.          Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 63.          Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 64.          Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 65.          Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 66.          India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 67.          India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68.          India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 69.          India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 70.          India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 71.          South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 72.          South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 73.          South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 74.          South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 75.          South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 76.          Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 77.          Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 78.          Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 79.          Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 80.          Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 81.          Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 82.          Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 83.          Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 84.          Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 85.          Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 86.          Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 87.          Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 88.          Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 89.          Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 90.          Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 91.          UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 92.          UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 93.          UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 94.          UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 95.          UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 96.          South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 97.          South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 98.          South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 99.          South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 100.       South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 101.       South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 102.       South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 103.       South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 104.       South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 105.       South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 106.       Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 107.       Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 108.       Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 109.       Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 110.       Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 111.       Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 112.       Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 113.       Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 114.       Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 115.       Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 116.       Organic Developments Done by Companies

Table 117.       Inorganic Developments Done by Companies

Table 118.       Glossary of Terms, Neuromodulation Market

 


 

LIST OF FIGURES

Figure 1.           Neuromodulation Market Segmentation

Figure 2.           Neuromodulation Market – By Geography

Figure 3.           Middle East & Africa Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market

Figure 5.           Saudi Arabia Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East and Africa Neuromodulation Market- Leading Country Markets (US$ Million)

Figure 7.           Middle East and Africa PEST Analysis

Figure 8.           Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 9.           Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 10.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 14.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 21.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 33.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Middle East and Africa: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        Middle East and Africa: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 38.        Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 39.        Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        South and Central America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 43.        South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 44.        South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 45.        Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        Impact of COVID-19 Pandemic in Rest of the World Country Market

 

The List of Companies - Middle East and Africa Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim

 

  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa neuromodulation market

 

  • Highlights key business priorities to assist companies in order to realign their business strategies

 

  • Highlights key findings and recommendations of crucial progressive industry trends in the Middle East & Africa neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies

 

  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets

 

  • Scrutinizes in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it

 

  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

 


Related Tags Middle East and Africa Neuromodulation Market Middle East and Africa Neuromodulation Market Research Middle East and Africa Neuromodulation Market Insight Middle East and Africa Neuromodulation Market Trends Middle East and Africa Neuromodulation Market Forecast Middle East and Africa Neuromodulation Market Share Middle East and Africa Neuromodulation Market 2027 Middle East and Africa Neuromodulation Market Growth Middle East and Africa Neuromodulation Industry Sector Middle East and Africa Neuromodulation PDF Report Middle East and Africa Neuromodulation Analysis Middle East and Africa Neuromodulation Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000